Sandra Hess

564 total citations
10 papers, 405 citations indexed

About

Sandra Hess is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Sandra Hess has authored 10 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Immunology and 2 papers in Pharmacology. Recurrent topics in Sandra Hess's work include interferon and immune responses (3 papers), Ubiquitin and proteasome pathways (3 papers) and Immunotherapy and Immune Responses (3 papers). Sandra Hess is often cited by papers focused on interferon and immune responses (3 papers), Ubiquitin and proteasome pathways (3 papers) and Immunotherapy and Immune Responses (3 papers). Sandra Hess collaborates with scholars based in Germany, Italy and Spain. Sandra Hess's co-authors include Klaus‐Peter Knobeloch, Bernd L. Fiebich, Eduardo Candelario‐Jalil, Klaus Lieb, Peter J. Gebicke‐Haerter, Ravi Shankar Akundi, Michael Hüll, Daniel J. Fernandez, G. Fritz and Huib Ovaa and has published in prestigious journals such as The Journal of Cell Biology, The EMBO Journal and Journal of Neurochemistry.

In The Last Decade

Sandra Hess

10 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Hess Germany 9 214 127 66 60 53 10 405
Julia Leemput France 10 167 0.8× 270 2.1× 64 1.0× 82 1.4× 33 0.6× 16 553
Francisco M. Lio United States 11 255 1.2× 262 2.1× 82 1.2× 137 2.3× 43 0.8× 12 584
Tanja Furtner Austria 12 194 0.9× 177 1.4× 79 1.2× 22 0.4× 24 0.5× 13 534
Binbin Li China 11 137 0.6× 146 1.1× 171 2.6× 44 0.7× 24 0.5× 16 449
Chunting Qi China 9 526 2.5× 216 1.7× 78 1.2× 62 1.0× 28 0.5× 15 706
Haya Hamza Israel 7 199 0.9× 82 0.6× 19 0.3× 68 1.1× 48 0.9× 12 429
Jessica A. Buckley United States 7 229 1.1× 162 1.3× 175 2.7× 85 1.4× 18 0.3× 10 570
Michal Irony-Tur-Sinai Israel 10 254 1.2× 89 0.7× 191 2.9× 30 0.5× 74 1.4× 10 525
Vijay P. Kale United States 11 215 1.0× 42 0.3× 26 0.4× 52 0.9× 31 0.6× 20 423
Andréia Barroso Brazil 7 137 0.6× 96 0.8× 105 1.6× 33 0.6× 12 0.2× 7 380

Countries citing papers authored by Sandra Hess

Since Specialization
Citations

This map shows the geographic impact of Sandra Hess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Hess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Hess more than expected).

Fields of papers citing papers by Sandra Hess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Hess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Hess. The network helps show where Sandra Hess may publish in the future.

Co-authorship network of co-authors of Sandra Hess

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Hess. A scholar is included among the top collaborators of Sandra Hess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Hess. Sandra Hess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hess, Sandra, et al.. (2021). SCF Fbxw5 targets kinesin‐13 proteins to facilitate ciliogenesis. The EMBO Journal. 40(18). e107735–e107735. 10 indexed citations
2.
Hess, Sandra, et al.. (2020). Interferon-stimulated gene 15 accelerates replication fork progression inducing chromosomal breakage. The Journal of Cell Biology. 219(8). 44 indexed citations
3.
Fernandez, Daniel J., Sandra Hess, & Klaus‐Peter Knobeloch. (2020). Strategies to Target ISG15 and USP18 Toward Therapeutic Applications. Frontiers in Chemistry. 7. 923–923. 37 indexed citations
4.
Basters, Anja, Paul P. Geurink, Annika Röcker, et al.. (2017). Structural basis of the specificity of USP18 toward ISG15. Nature Structural & Molecular Biology. 24(3). 270–278. 89 indexed citations
5.
Mousset, Sabine, Hans Martin, Annemarie Berger, et al.. (2011). Human herpesvirus 6 in biopsies from patients with gastrointestinal symptoms after allogeneic stem cell transplantation. Annals of Hematology. 91(5). 737–742. 4 indexed citations
6.
Böhm, Beate, et al.. (2010). ADAM15 exerts an antiapoptotic effect on osteoarthritic chondrocytes via up‐regulation of the X‐linked inhibitor of apoptosis. Arthritis & Rheumatism. 62(5). 1372–1382. 28 indexed citations
7.
Navarrete, Carmen, Bernd L. Fiebich, Amaya García de Vinuesa, et al.. (2009). Opposite effects of anandamide andn‐arachidonoyl dopamine in the regulation of prostaglandin E2and 8‐iso‐PGFformation in primary glial cells. Journal of Neurochemistry. 109(2). 452–464. 26 indexed citations
8.
Caballero, Francisco J., Carmen Navarrete, Sandra Hess, et al.. (2006). The acetaminophen-derived bioactive N-acylphenolamine AM404 inhibits NFAT by targeting nuclear regulatory events. Biochemical Pharmacology. 73(7). 1013–1023. 19 indexed citations
9.
Akundi, Ravi Shankar, Eduardo Candelario‐Jalil, Sandra Hess, et al.. (2005). Signal transduction pathways regulating cyclooxygenase‐2 in lipopolysaccharide‐activated primary rat microglia. Glia. 51(3). 199–208. 121 indexed citations
10.
Schröder, Oliver, Sandra Hess, W. F. Caspary, & Jürgen M. Stein. (1999). Mediation of differentiating effects of Butyrate on the intestinal cell line Caco-2 by transforming growth factor-β1. European Journal of Nutrition. 38(1). 45–50. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026